Artwork

Inhoud geleverd door Academy of Technology and Engineering and Academy of Technology. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Academy of Technology and Engineering and Academy of Technology of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

TechNOW podcast: Breathable treatment for drug-resistant TB

22:03
 
Delen
 

Manage episode 305801324 series 2350225
Inhoud geleverd door Academy of Technology and Engineering and Academy of Technology. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Academy of Technology and Engineering and Academy of Technology of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
COVID isn’t the only pandemic threat we face. The infectious disease that killed the most people in 2018 wasn’t malaria or HIV: it was tuberculosis. Because of antibiotic resistance, a growing number of TB infections can’t be cured by current methods. Rising fever, chest-pain, coughing up blood – without new treatments, this ancient sickness could become a future crisis. But what if we could treat antibiotic resistant TB with a new drug delivered straight into the lungs by an asthma-puffer style device? Thanks to new technology developed by Associate Professor Charlotte Conn, her team at RMIT, and their collaborators in India, this dream cure could become a reality. TechNOW is a podcast about Australian innovations that are shaping the future, thanks to the Global Connections fund – a project run by the Australian Academy of Technology and Engineering and supported by the Australian Government.
  continue reading

11 afleveringen

Artwork
iconDelen
 
Manage episode 305801324 series 2350225
Inhoud geleverd door Academy of Technology and Engineering and Academy of Technology. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Academy of Technology and Engineering and Academy of Technology of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
COVID isn’t the only pandemic threat we face. The infectious disease that killed the most people in 2018 wasn’t malaria or HIV: it was tuberculosis. Because of antibiotic resistance, a growing number of TB infections can’t be cured by current methods. Rising fever, chest-pain, coughing up blood – without new treatments, this ancient sickness could become a future crisis. But what if we could treat antibiotic resistant TB with a new drug delivered straight into the lungs by an asthma-puffer style device? Thanks to new technology developed by Associate Professor Charlotte Conn, her team at RMIT, and their collaborators in India, this dream cure could become a reality. TechNOW is a podcast about Australian innovations that are shaping the future, thanks to the Global Connections fund – a project run by the Australian Academy of Technology and Engineering and supported by the Australian Government.
  continue reading

11 afleveringen

Alle afleveringen

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding